Targeting the miR-34a/LRPPRC/MDR1 Axis Collapse the Chemoresistance in P53 Inactive Colorectal Cancer

Researchers demonstrated and reported for the first time that leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) was a key functional downstream factor and therapeutic target for P53 mutation-induced chemoresistance.